Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-04-29

Clinical Trial Update: Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on radio-guided lymph node dissection for oligometastatic prostate cancer, encompassing Phase 1 and Phase 2 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Radboud University Medical Center | Conditions: Prostate Cancer, Lymph Node Metastases | Phase 1, Phase 2 | Status: UNKNOWN